Mumbai, Jan 28 (IANS) Pharmaceutical major Cipla on Tuesday reported a 49 per cent year-on-year (YoY) increase in its consolidated net profit for the December quarter (Q3 FY25) at Rs 1,574.6 crore, from Rs 1,068.5 crore in the same quarter last year (Q2 FY25).
The company’s revenue from operations grew by 7 per cent YoY to Rs 7,073 crore, compared to Rs 6,604 crore in Q3 FY24, according to its exchange filing.
However, it remained nearly flat on a quarter-on-quarter (QoQ) basis, with revenue standing at Rs 7,051 crore in Q2 FY25.
Revenue from its India business grew by 10 per cent YoY to Rs 3,146 crore, with its branded prescription business outperforming market growth in key therapies.
Cipla’s EBITDA for the quarter rose by 15.7 per cent YoY to Rs 1,989 crore, while the EBITDA margin improved by 184 basis points to 28.1 per cent.
The company said its sustained margins were a result of improved operational efficiencies and its deep market-focused strategy.
However, Cipla’s expenses for the quarter increased by 5 per cent YoY to Rs 5,378 crore, though they were 1.3 per cent lower on a QoQ basis.
Cipla’s new ventures segment also performed well, delivering revenue of Rs 341 crore in Q3 FY25, up from Rs 281 crore in Q3 FY24 and Rs 320 crore in the previous quarter.
According to its filing, the company’s growth was driven by robust performance in emerging markets and Europe.
Cipla also noted that its trade generics segment is back on a growth trajectory, and its consumer health brands continue to expand.
Following the results, the company’s stock closed by Rs 30.9 up at Rs 1,427 apiece.
–IANS
pk/na
Disclaimer
The information contained in this website is for general information purposes only. The information is provided by BhaskarLive.in and while we endeavour to keep the information up to date and correct, we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, reliability, suitability or availability with respect to the website or the information, products, services, or related graphics contained on the website for any purpose. Any reliance you place on such information is therefore strictly at your own risk.
In no event will we be liable for any loss or damage including without limitation, indirect or consequential loss or damage, or any loss or damage whatsoever arising from loss of data or profits arising out of, or in connection with, the use of this website.
Through this website you are able to link to other websites which are not under the control of BhaskarLive.in We have no control over the nature, content and availability of those sites. The inclusion of any links does not necessarily imply a recommendation or endorse the views expressed within them.
Every effort is made to keep the website up and running smoothly. However, BhaskarLive.in takes no responsibility for, and will not be liable for, the website being temporarily unavailable due to technical issues beyond our control.
For any legal details or query please visit original source link given with news or click on Go to Source.
Our translation service aims to offer the most accurate translation possible and we rarely experience any issues with news post. However, as the translation is carried out by third part tool there is a possibility for error to cause the occasional inaccuracy. We therefore require you to accept this disclaimer before confirming any translation news with us.
If you are not willing to accept this disclaimer then we recommend reading news post in its original language.
